The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.

Find Out What It Is Right Here.

PCSA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 26.50%

Insider Buying (Last 12 Months): $20,000.00

Insider Selling (Last 12 Months): $0.00

Processa Pharmaceuticals Insider Trading History Chart

Processa Pharmaceuticals Share Price & Price History

^$0.61

▼ -0.0149 (-2.40%)

As of 06/1/2023 06:11 PM ET

Days: 30 | 90 | 365

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

Processa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/13/2023	David Young	CEO	Buy	20,000	$0.48	$9,600.00	410,424
4/11/2023	David Young	CEO	Buy	20,000	$0.52	$10,400.00	370,424
5/17/2022	Patrick Lin	Insider	Buy	2,000	$1.59	$3,180.00	433,390
4/6/2022	Patrick Lin	Insider	Buy	1,200	$3.13	$3,756.00	431,390
1/27/2022	Justin W. Yorke	Director	Sell	1,854	$3.30	$6,118.20
12/14/2021	Patrick Lin	Insider	Buy	3,000	$4.00	$12,000.00
12/6/2021	Justin W. Yorke	Director	Sell	4,200	$4.71	$19,782.00
12/3/2021	Justin W. Yorke	Director	Sell	5,500	$4.84	$26,620.00
12/3/2021	Patrick Lin	Insider	Buy	3,500	$4.80	$16,800.00
8/26/2021	Patrick Lin	Insider	Buy	4,000	$6.02	$24,080.00	422,890
6/23/2021	David Young	CEO	Buy	10,000	$7.67	$76,700.00	345,190
6/22/2021	Robert Michael Floyd	COO	Buy	2,000	$7.03	$14,060.00	28,000
6/21/2021	James H. Stanker	CFO	Buy	1,000	$6.81	$6,810.00	36,510
4/13/2021	Justin W. Yorke	Director	Sell	6,500	$9.86	$64,090.00	300,706
4/13/2021	Justin W. Yorke	Director	Sell	6,500	$9.86	$64,090.00	300,706
4/8/2021	James E Besser	Insider	Sell	400,000	$10.76	$4,304,000.00	1,064,300
4/6/2021	James E Besser	Insider	Sell	31,771	$10.91	$346,621.61	1,064,300
2/22/2021	James E Besser	Major Shareholder	Sell	20,929	$11.56	$241,939.24	1,120,000
2/18/2021	James E Besser	Major Shareholder	Sell	5,000	$11.35	$56,750.00	1,120,000
10/2/2020	James E Besser	Major Shareholder	Buy	30,000	$4.04	$121,200.00	405,000

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

SEC Filings (Institutional Ownership Changes) for Processa Pharmaceuticals (NASDAQ:PCSA)

7.15% of Processa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Processa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/15/2023	Two Sigma Securities LLC	62,626	$31K	0.0%	N/A	0.255%
2/8/2023	Raymond James Financial Services Advisors Inc.	48,951	$54K	0.0%	N/A	0.306%
11/10/2022	Dimensional Fund Advisors LP	12,466	$28K	0.0%	N/A	0.079%
8/13/2022	Renaissance Technologies LLC	11,600	$33K	0.0%	N/A	0.073%
8/5/2022	Coastal Bridge Advisors LLC	52,500	$0.15M	0.0%	+61.5%	0.331%
2/15/2022	Coastal Bridge Advisors LLC	32,500	$0.16M	0.0%	+18.2%	0.207%
2/10/2022	AIGH Capital Management LLC	303,703	$1.49M	0.5%	-21.5%	1.932%
1/26/2022	Verdence Capital Advisors LLC	63,227	$0.31M	0.0%	-14.3%	0.402%
10/29/2021	Janney Montgomery Scott LLC	46,231	$0.40M	0.0%	-18.5%	0.296%
8/16/2021	State Street Corp	16,600	$0.14M	0.0%	N/A	0.107%
8/13/2021	Geode Capital Management LLC	37,400	$0.31M	0.0%	+34.4%	0.240%
8/13/2021	Vanguard Group Inc.	373,171	$3.06M	0.0%	+136.7%	2.397%
8/10/2021	Coastal Bridge Advisors LLC	27,500	$0.23M	0.0%	+37.5%	0.177%
8/9/2021	Vectors Research Management LLC	4,000	$33K	0.0%	N/A	0.026%
5/21/2021	Citadel Advisors LLC	13,117	$0.14M	0.0%	N/A	0.085%
5/19/2021	Worth Venture Partners LLC	90,968	$0.94M	0.5%	N/A	0.586%
5/18/2021	Millennium Management LLC	93,999	$1.03M	0.0%	-12.0%	0.606%
5/18/2021	Citadel Advisors LLC	13,117	$0.14M	0.0%	N/A	0.085%
5/17/2021	Coastal Bridge Advisors LLC	20,000	$0.22M	0.0%	N/A	0.129%
5/12/2021	Northern Trust Corp	12,845	$0.14M	0.0%	N/A	0.083%
5/12/2021	Geode Capital Management LLC	27,825	$0.30M	0.0%	N/A	0.179%
5/12/2021	Essex Investment Management Co. LLC	72,908	$0.80M	0.1%	-2.7%	0.470%
5/4/2021	Commonwealth Equity Services LLC	10,550	$0.12M	0.0%	N/A	0.068%
4/27/2021	Janney Montgomery Scott LLC	63,331	$0.69M	0.0%	-4.5%	0.408%
2/13/2021	Essex Investment Management Co. LLC	74,928	$0.49M	0.1%	N/A	0.709%

Data available starting January 2016

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.

Today's Range

Now: $0.61

$0.59

$0.67

50 Day Range

MA: $0.57

$0.44

$0.72

52 Week Range

Now: $0.61

$0.36

$3.83

Volume

46,677 shs

Average Volume

198,670 shs

Market Capitalization

$14.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Who are the company insiders with the largest holdings of Processa Pharmaceuticals?: Processa Pharmaceuticals' top insider investors include:
Patrick Lin (Insider)
David Young (CEO)
James H Stanker (CFO)
Robert Michael Floyd (COO)
Justin W Yorke (Director)
Learn More about top insider investors at Processa Pharmaceuticals.
Who are the major institutional investors of Processa Pharmaceuticals?: Processa Pharmaceuticals' top institutional investors include:
Two Sigma Securities LLC — 0.26%
Learn More about top institutional investors of Processa Pharmaceuticals stock.
Which institutional investors are buying Processa Pharmaceuticals stock?: Within the last quarter, PCSA stock was bought by institutional investors including:
Two Sigma Securities LLC
Within the previous year, these company insiders have bought Processa Pharmaceuticals stock:
Patrick Lin (Insider)
David Young (CEO)
James H Stanker (CFO)
Robert Michael Floyd (COO)
Learn More investors buying Processa Pharmaceuticals stock.